Quality assessment of the guidelines for the management of malignant pleural effusions and ascites
2020 · World Journal of Surgical Oncology · 18 citations
https://doi.org/10.1186/s12957-020-02097-y
Y
Yanmei Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
328
Citations
11
h-index
13
i10-index
Yanmei Shi is an academic researcher from Ningbo University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Retinal Diseases and Treatments & Immunotherapy and Immune Responses. The author has an h-index of 11, co-authored 36 publications.
ORCID: 0000-0001-8038-9703Papers by this author
worksElevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
2025 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-024-84649-w
Increased long-term central memory T cells in patients with retreatment pulmonary tuberculosis
2025 · Frontiers in Immunology · 2 citations
https://doi.org/10.3389/fimmu.2025.1545537
Supplementary material from "miR-149-3p reverses CD8<sup>+</sup> T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells"
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.4676036.v1
Table S1. miRNA that are differentially expressed in CD8+PD-1+ vs. CD8+PD-1- T cells from miR-149-3p reverses CD8<sup>+</sup> T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9896825.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat